Cargando…

Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease

Cerebral small vessel disease (cSVD) affects arterioles, capillaries, and venules and can lead to cognitive impairments and clinical symptomatology of vascular cognitive impairment and dementia (VCID). VCID symptoms are similar to Alzheimer’s disease (AD) but the neurophysiologic alterations are les...

Descripción completa

Detalles Bibliográficos
Autores principales: Jann, Kay, Shao, Xingfeng, Ma, Samantha J., Cen, Steven Y., D’Orazio, Lina, Barisano, Giuseppe, Yan, Lirong, Casey, Marlena, Lamas, Jesse, Staffaroni, Adam M., Kramer, Joel H., Ringman, John M., Wang, Danny J. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873482/
https://www.ncbi.nlm.nih.gov/pubmed/33584191
http://dx.doi.org/10.3389/fnins.2021.627627
_version_ 1783649395095371776
author Jann, Kay
Shao, Xingfeng
Ma, Samantha J.
Cen, Steven Y.
D’Orazio, Lina
Barisano, Giuseppe
Yan, Lirong
Casey, Marlena
Lamas, Jesse
Staffaroni, Adam M.
Kramer, Joel H.
Ringman, John M.
Wang, Danny J. J.
author_facet Jann, Kay
Shao, Xingfeng
Ma, Samantha J.
Cen, Steven Y.
D’Orazio, Lina
Barisano, Giuseppe
Yan, Lirong
Casey, Marlena
Lamas, Jesse
Staffaroni, Adam M.
Kramer, Joel H.
Ringman, John M.
Wang, Danny J. J.
author_sort Jann, Kay
collection PubMed
description Cerebral small vessel disease (cSVD) affects arterioles, capillaries, and venules and can lead to cognitive impairments and clinical symptomatology of vascular cognitive impairment and dementia (VCID). VCID symptoms are similar to Alzheimer’s disease (AD) but the neurophysiologic alterations are less well studied, resulting in no established biomarkers. The purpose of this study was to evaluate cerebral blood flow (CBF) measured by 3D pseudo-continuous arterial spin labeling (pCASL) as a potential biomarker of VCID in a cohort of elderly Latinx subjects at risk of cSVD. Forty-five elderly Latinx subjects (12 males, 69 ± 7 years) underwent repeated MRI scans ∼6 weeks apart. CBF was measured using 3D pCASL in the whole brain, white matter and 4 main vascular territories (leptomeningeal anterior, middle, and posterior cerebral artery (leptoACA, leptoMCA, leptoPCA), as well as MCA perforator). The test-retest repeatability of CBF was assessed by intra-class correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). Absolute and relative CBF was correlated with gross cognitive measures and domain specific assessment of executive and memory function, vascular risks, and Fazekas scores and volumes of white matter hyperintensity (WMH). Neurocognitive evaluations were performed using Montreal Cognitive Assessment (MoCA) and neuropsychological test battery in the Uniform Data Set v3 (UDS3). Good to excellent test-retest repeatability was achieved (ICC = 0.77–0.85, wsCV 3–9%) for CBF measurements in the whole brain, white matter, and 4 vascular territories. Relative CBF normalized by global mean CBF in the leptoMCA territory was positively correlated with the executive function composite score, while relative CBF in the leptoMCA and MCA perforator territory was positively correlated with MoCA scores, controlling for age, gender, years of education, and testing language. Relative CBF in WM was negatively correlated with WMH volume and MoCA scores, while relative leptoMCA CBF was positively correlated with WMH volume. Reliable 3D pCASL CBF measurements were achieved in the cohort of elderly Latinx subjects. Relative CBF in the leptomeningeal and perforator MCA territories were the most likely candidate biomarker of VCID. These findings need to be replicated in larger cohorts with greater variability of stages of cSVD.
format Online
Article
Text
id pubmed-7873482
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78734822021-02-11 Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease Jann, Kay Shao, Xingfeng Ma, Samantha J. Cen, Steven Y. D’Orazio, Lina Barisano, Giuseppe Yan, Lirong Casey, Marlena Lamas, Jesse Staffaroni, Adam M. Kramer, Joel H. Ringman, John M. Wang, Danny J. J. Front Neurosci Neuroscience Cerebral small vessel disease (cSVD) affects arterioles, capillaries, and venules and can lead to cognitive impairments and clinical symptomatology of vascular cognitive impairment and dementia (VCID). VCID symptoms are similar to Alzheimer’s disease (AD) but the neurophysiologic alterations are less well studied, resulting in no established biomarkers. The purpose of this study was to evaluate cerebral blood flow (CBF) measured by 3D pseudo-continuous arterial spin labeling (pCASL) as a potential biomarker of VCID in a cohort of elderly Latinx subjects at risk of cSVD. Forty-five elderly Latinx subjects (12 males, 69 ± 7 years) underwent repeated MRI scans ∼6 weeks apart. CBF was measured using 3D pCASL in the whole brain, white matter and 4 main vascular territories (leptomeningeal anterior, middle, and posterior cerebral artery (leptoACA, leptoMCA, leptoPCA), as well as MCA perforator). The test-retest repeatability of CBF was assessed by intra-class correlation coefficient (ICC) and within-subject coefficient of variation (wsCV). Absolute and relative CBF was correlated with gross cognitive measures and domain specific assessment of executive and memory function, vascular risks, and Fazekas scores and volumes of white matter hyperintensity (WMH). Neurocognitive evaluations were performed using Montreal Cognitive Assessment (MoCA) and neuropsychological test battery in the Uniform Data Set v3 (UDS3). Good to excellent test-retest repeatability was achieved (ICC = 0.77–0.85, wsCV 3–9%) for CBF measurements in the whole brain, white matter, and 4 vascular territories. Relative CBF normalized by global mean CBF in the leptoMCA territory was positively correlated with the executive function composite score, while relative CBF in the leptoMCA and MCA perforator territory was positively correlated with MoCA scores, controlling for age, gender, years of education, and testing language. Relative CBF in WM was negatively correlated with WMH volume and MoCA scores, while relative leptoMCA CBF was positively correlated with WMH volume. Reliable 3D pCASL CBF measurements were achieved in the cohort of elderly Latinx subjects. Relative CBF in the leptomeningeal and perforator MCA territories were the most likely candidate biomarker of VCID. These findings need to be replicated in larger cohorts with greater variability of stages of cSVD. Frontiers Media S.A. 2021-01-27 /pmc/articles/PMC7873482/ /pubmed/33584191 http://dx.doi.org/10.3389/fnins.2021.627627 Text en Copyright © 2021 Jann, Shao, Ma, Cen, D’Orazio, Barisano, Yan, Casey, Lamas, Staffaroni, Kramer, Ringman and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Jann, Kay
Shao, Xingfeng
Ma, Samantha J.
Cen, Steven Y.
D’Orazio, Lina
Barisano, Giuseppe
Yan, Lirong
Casey, Marlena
Lamas, Jesse
Staffaroni, Adam M.
Kramer, Joel H.
Ringman, John M.
Wang, Danny J. J.
Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title_full Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title_fullStr Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title_full_unstemmed Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title_short Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease
title_sort evaluation of cerebral blood flow measured by 3d pcasl as biomarker of vascular cognitive impairment and dementia (vcid) in a cohort of elderly latinx subjects at risk of small vessel disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873482/
https://www.ncbi.nlm.nih.gov/pubmed/33584191
http://dx.doi.org/10.3389/fnins.2021.627627
work_keys_str_mv AT jannkay evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT shaoxingfeng evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT masamanthaj evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT censteveny evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT doraziolina evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT barisanogiuseppe evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT yanlirong evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT caseymarlena evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT lamasjesse evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT staffaroniadamm evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT kramerjoelh evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT ringmanjohnm evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease
AT wangdannyjj evaluationofcerebralbloodflowmeasuredby3dpcaslasbiomarkerofvascularcognitiveimpairmentanddementiavcidinacohortofelderlylatinxsubjectsatriskofsmallvesseldisease